Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saul Carcamo

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cell Reports. Medicine|December 3, 2024
Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitorsEsra Karakose, Xuedi Wang, Peng Wang, et al.
Blood Cancer Discovery|April 17, 2023
Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid LeukemiaAndriana G Kotini, Saul Carcamo, Nataly Cruz-Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
A CRISPR-Based Humanized Model Reveals Cooperative Role of STAG2 Loss in Familial GATA2-Deficient MDS ProgressionGrace Freed, Miguel Quijada-Álamo, Linda Lee, et al.
Cell Reports|April 6, 2022
Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanomaSaul Carcamo, Christie B Nguyen, Elena Grossi, et al.
Nature Communications|August 26, 2018
SIRT6 haploinsufficiency induces BRAF<sup>V600E</sup> melanoma cell resistance to MAPK inhibitors via IGF signallingThomas Strub, Flavia G Ghiraldini, Saul Carcamo, et al.
Cancer Discovery|September 7, 2023
p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 ExpressionGizem Efe, Karen J Dunbar, Kensuke Sugiura, et al.
Nature Cell Biology|August 21, 2023
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin loopingDan Filipescu, Saul Carcamo, Aman Agarwal, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
Nature|October 31, 2024
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclaxJunya Sango, Saul Carcamo, Maria Sirenko, et al.
Communications Biology|February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogrammingWazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cell Reports. Medicine|December 3, 2024
Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitorsEsra Karakose, Xuedi Wang, Peng Wang, et al.
Blood Cancer Discovery|April 17, 2023
Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid LeukemiaAndriana G Kotini, Saul Carcamo, Nataly Cruz-Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
A CRISPR-Based Humanized Model Reveals Cooperative Role of STAG2 Loss in Familial GATA2-Deficient MDS ProgressionGrace Freed, Miguel Quijada-Álamo, Linda Lee, et al.
Cell Reports|April 6, 2022
Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanomaSaul Carcamo, Christie B Nguyen, Elena Grossi, et al.
Nature Communications|August 26, 2018
SIRT6 haploinsufficiency induces BRAF<sup>V600E</sup> melanoma cell resistance to MAPK inhibitors via IGF signallingThomas Strub, Flavia G Ghiraldini, Saul Carcamo, et al.
Cancer Discovery|September 7, 2023
p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 ExpressionGizem Efe, Karen J Dunbar, Kensuke Sugiura, et al.
Nature Cell Biology|August 21, 2023
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin loopingDan Filipescu, Saul Carcamo, Aman Agarwal, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
Nature|October 31, 2024
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclaxJunya Sango, Saul Carcamo, Maria Sirenko, et al.
Communications Biology|February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogrammingWazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Pageof 3